Standard Biotools Inc
(LAB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -39,218 | -25,465 | -59,013 | -44,238 | -29,488 |
| Depreciation Amortization | 9,738 | 6,028 | 24,951 | 18,238 | 11,615 |
| Accounts receivable | -2,420 | -2,483 | -1,788 | -3,285 | -1,814 |
| Accounts payable and accrued liabilities | 3,439 | 2,649 | -294 | 2,054 | 2,445 |
| Other Working Capital | -10,672 | -12,144 | -3,568 | -4,660 | -6,339 |
| Other Operating Activity | 13,990 | 11,285 | 14,511 | 7,328 | 3,082 |
| Operating Cash Flow | $-25,143 | $-20,130 | $-25,201 | $-24,563 | $-20,499 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -685 | -266 | -372 | -352 | -154 |
| Purchase Of Investment | -44,614 | -9,491 | -1,450 | -1,451 | -1,451 |
| Sale Of Investment | N/A | N/A | 6,541 | 6,541 | 5,541 |
| Investing Cash Flow | $-45,299 | $-9,757 | $4,719 | $4,738 | $3,936 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | -2,862 | N/A | N/A |
| Common Stock Issued | 1,689 | 255 | 60,880 | 654 | 641 |
| Other Financing Activity | -502 | -108 | -358 | -2,946 | -2,793 |
| Financing Cash Flow | $1,187 | $147 | $57,660 | $-2,292 | $-2,152 |
| Exchange Rate Effect | -25 | -27 | 167 | -110 | 83 |
| Beginning Cash Position | 95,401 | 95,401 | 58,056 | 58,056 | 58,056 |
| End Cash Position | 26,121 | 65,634 | 95,401 | 35,829 | 39,424 |
| Net Cash Flow | $-69,280 | $-29,767 | $37,345 | $-22,227 | $-18,632 |
| Free Cash Flow | |||||
| Operating Cash Flow | -25,143 | -20,130 | -25,201 | -24,563 | -20,499 |
| Capital Expenditure | -685 | -266 | -372 | -352 | -154 |
| Free Cash Flow | -25,828 | -20,396 | -25,573 | -24,915 | -20,653 |